Risk Group and Biosafety Level. Classification of Infective Agents by Risk Group Pathogenicity Pathogenicity Infectious Dose Infectious Dose Mode of Transmission.

Slides:



Advertisements
Similar presentations
Biological Agents.
Advertisements

OVERVIEW OF INDUSTRIAL HYGIENE UNIVERSITY OF HOUSTON – DOWNTOWN CAMPUS.
The Chain of Infection. As healthcare professionals, it is important to understand two facts about infection As healthcare professionals, it is important.
2008 In-Service Law Enforcement Training Training Objectives Explain the purpose of the Bloodborne Pathogen Standard in 29 CFR Describe the.
Biosafety in Microbiologic and Biomedical Laboratories The University of Texas at Tyler IACUC Education and Training *Note: Content not specific to UT.
Biosafety in the TB Laboratory
Biosafety and Facility Design
Health and Safety in the Laboratory
Laboratory Biosafety Pathogenic Microbiology and Virology Laboratories.
Biocontainment Practices Inside the Animal Lab
Lab Biosafety INTRODUCED BY ENAS A. RAOUF MOHAMMED CECR RESEARCH ASSISTANT SUPERVISED BY PROF. MOHAMED L. SALEM CECR DIRECTOR.
© 2012 O’Brien & Gere # obgPresentation Are there Microbes Lurking? June 12, 2012 | State University of NY Paul W. Tranchell CIH, CSP, RBP Project Manager.
Copyright © 2006 Thomson Delmar Learning. ALL RIGHTS RESERVED. 1 PowerPoint ® Presentation for Introduction to Dental Assisting Module: Disease Prevention.
Nueces County Safety Training Training Objectives Explain the purpose of the Bloodborne Pathogen Standard in 29 CFR Describe the general symptoms.
Bloodborne Pathogens. What are Bloodborne Pathogens? Bloodborne Pathogens Bacteria Virus.
BIOLOGICAL HAZARDS RISK ASSESSMENT
Patient Safety Monitoring in International Laboratories (SMILE) 1 Biosafety in the Clinical Laboratory A SMILE Presentation.
An Introduction to Biological Safety Dr. A. Mantalaris Biological Safety Officer (ACE 515, Tel: x45601)
Pathogenic Microbiology
BIOSAFETY. BIORISK ASSESSMENT
It’s safety and I know it!. The Chain of Infection.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
General Biosafety Tassanee Eamkamon Biosafety Professional Armed Forces Research Institute of Medical Sciences 23 March 2010.
Biosafety in the Clinical Microbiology Lab Mohammad Rahbar (PhD) Associated Professor Iranian Health Reference Laboratory.
National Institute for Cellular Biotechnology Safelab II Basic Biological Safety Robert O’Connor Ph.D DCU Biological Safety Advisor
Mandatory Inservice INFECTION CONTROL. At the completion of this module the participant will be able to:  Define Standard Precautions  Discuss The Chain.
2. BIOLOGICAL HAZARDS RYERSON UNIVERSITY.
Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee.
Disease Transmission In Dentistry Dr. Shahzadi Tayyaba Hashmi
Risk Assessment. Risk As defined by Kaplan and Garrick, risk analysis consists of answering three specific questions: what can happen? what is the chance.
CGMP Biopharmaceutical Facility Basic Construction.
Safety. Four Simple Questions What are the hazards? What are the hazards? What are the worst things that could happen? What are the worst things that.
Chapter 3: Infection Control Outline Disease Transmission and Occupational Exposure Infection Control Agencies and Regulations Infection Control Techniques.
General Requirements for a BSL-3/4 Laboratory
Introduction to Biohazards: Risk Management
Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
Communicable Disease Disease passed from one person to another.
Bloodborne Pathogens. What are Bloodborne Pathogens? Bloodborne Pathogens Bacteria Virus.
Chapter 3 Infection Control. Copyright © 2007 Thomson Delmar Learning. ALL RIGHTS RESERVED.2 Spread of Infection How infection is spread: –Direct contact.
Bloodborne Pathogens Training: Preventing Disease Transmission
Bioscience Safety Unit PROPERTY OF PIMA COUNTY JTED,
52 Table 1. Summary of Recommended Biosafety Levels for Infectious Agents. Biosafety Level Agents Practices Safety Equipment (Primary Barriers) Facilities.
BIOSAFETY LEVEL 2 AWARENESS TRAINING UW Stout Laboratory Safety Biological Safety.
2.02 Transmitting Infection Understand infection control procedures Transmitting Infection Direct contact Direct contact Indirect contact Indirect.
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
RCSD Bloodborne Pathogen Protection Program Presented by Suzanne Wheatcraft, MS, CPG Director of School Environmental Health & Safety.
The Chain of Infection.
The Chain of Infection.
Comply with Infection Control Policies and Procedures in Health Work
The Chain of Infection.
CHAPTER 15 Biological Hazards.
Biosafety Overview for Laboratories
Laboratory Biosafety and Biosecurity
The Chain of Infection.
Working with Biological Hazards
PROTECTION FROM INJURY AND DISEASE
IACUC Occupational Health & Safety Programs
2.02 Transmitting Infection
The Chain of Infection.
BSL-1 Laboratory BIOHAZARD
رعایت اصول ایمنی در آزمایشگاه
2.02 Transmitting Infection
2.02 Transmitting Infection
The Chain of Infection.
2.02 Transmitting Infection
2.02 Transmitting Infection
Unit 2.02 (ppt 3) Transmitting Infection
Biosafety Principles: Separation, Seclusion & Containment
Presentation transcript:

Risk Group and Biosafety Level

Classification of Infective Agents by Risk Group Pathogenicity Pathogenicity Infectious Dose Infectious Dose Mode of Transmission Mode of Transmission Host Range Host Range Availability of Effective Preventive Measures and Treatment Availability of Effective Preventive Measures and Treatment

Classification of Infective Agents by Risk Group Risk Group 1Risk Group 2Risk Group 3Risk Group 4 Severity of Disease unlikely to cause human or animal disease can cause disease, unlikely to be serious, effective treatment and preventive measures available can cause serious disease, does not ordinarily spread from one person to another, effective treatment and preventive measures usually available, exposure route: inhalation (often) likely to cause serious or lethal disease, can be readily transmitted from one individual to another, effective treatment and preventive measures are not usually available, transmission: direct, indirect, inhalation Host Rangehuman (healthy adult) and animals Individual Risk lowmoderate (potential hazard) high Community Risk low high

Classification of Containment by Biosafety Levels Practices and Procedures Practices and Procedures Containment Equipment (Primary Barriers) Containment Equipment (Primary Barriers) Containment Facility (Secondary Barriers) Containment Facility (Secondary Barriers) Note: CDC/NIH has 4 biosafety level classifications currently in use. Each level is appropriate for:  Operations Performed  Routes of Transmission (ingestion, inoculation, inhalation, mucous membrane exposure)  Laboratory Function

Risk Group and Biosafety Level Classifications Not appropriate to use risk group or biosafety level when assessing toxins. Not appropriate to use risk group or biosafety level when assessing toxins. Can be found in the American Biological Safety Association website: Can be found in the American Biological Safety Association website: Risk Groups and Biosafety Levels are not always the same! Risk Groups and Biosafety Levels are not always the same!